
    
      An open, multicentric, post-marketing surveillance study to monitor the safety and
      reactogenicity of GlaxoSmithKline Biologicals. Poliomyelitis vaccine (inactivated)
      -PoliorixTM., administered in Korean children as a primary vaccination in healthy subjects
      aged two to six months or as a booster vaccination in subjects aged four to six years.
    
  